IS IT POSSIBLE TO DIAGNOSE LOW RISK MYELODYSPLASTIC SYNDROME (MDS) BY FLOW CYTOMETRY?

被引：0
|
作者：
Atilla, E. [1 ]
Atilla, P. Ataca [1 ]
Turedi, O. [2 ]
Bozdag, S. Civriz [1 ]
Toprak, S. Kocak [1 ]
Akan, H. [1 ]
Beksac, M. [1 ]
Arslan, O. [1 ]
Topcuoglu, P. [1 ]
Ozcan, M. [1 ]
Ilhan, O. [1 ]
Ruhi, H. I. [2 ]
Gurman, G. [1 ]
Dalva, K. [1 ]
机构：
[1] Ankara Univ, Sch Med, Dept Hematol, Ankara, Turkey
[2] Ankara Univ, Sch Med, Dept Genet, Ankara, Turkey
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1227
引用
收藏
页码：506 / 506
页数：1
相关论文
共 50 条
  • [21] Engraftment of Immature Hematopoietic Low Risk Myelodysplastic Syndrome (MDS) Cells in Conjunction with MSCs
    Medyouf, H.
    Nolte, F.
    Mossner, M.
    Nowak, V.
    Zens, B.
    Muedder, K.
    Oblaender, J.
    St Fey
    Klaumuenzer, M.
    Fabarius, A.
    Riedl, E.
    Marx, A.
    Roehl, H.
    Mueller, N.
    Metzgeroth, G.
    Huetter, G.
    Hofmann, W. K.
    Nowak, D.
    Trumpp, A.
    ANNALS OF HEMATOLOGY, 2013, 92 : S59 - S59
  • [22] Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow Cytometry Working Group
    Loosdrecht, Arjan A.
    Kern, Wolfgang
    Porwit, Anna
    Valent, Peter
    Kordasti, Sharham
    Cremers, Eline
    Alhan, Canan
    Duetz, Carolien
    Dunlop, Alan
    Hobo, Willemijn
    Preijers, Frank
    Wagner-Ballon, Orianne
    Chapuis, Nicolas
    Fontenay, Michaela
    Bettelheim, Peter
    Eidenschink-Brodersen, Lisa
    Font, Patricia
    Johansson, Ulrika
    Loken, Michael R.
    Marvelde, Jeroen G.
    Matarraz, Sergio
    Ogata, Kiyoyuki
    Oelschlaegel, Uta
    Orfao, Alberto
    Psarra, Katherina
    Subira, Dolores
    Wells, Denise A.
    Bene, Marie C.
    Della Porta, Matteo G.
    Burbury, Kate
    Bellos, Frauke
    van der Velden, Vincent H. J.
    Westers, Theresia M.
    Saft, Leonie
    Ireland, Robin
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2023, 104 (01) : 77 - 86
  • [23] A flow cytometry panel useful to exclude myelodysplastic syndrome
    Zhang, Ling
    Lee, Stephen
    Lopategui, Jean
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2006, 70B (05) : 378 - 378
  • [24] Contributions of flow cytometry in the evaluation of myelodysplastic syndrome patients
    Mansour, Amany H.
    Kassm, Eman
    Elkhodary, Tawfik
    Taha, Samar
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2013, 38 (04): : 141 - 148
  • [25] Excessive apoptosis in low risk myelodysplastic syndromes (MDS)
    Parker, JE
    Mufti, GJ
    LEUKEMIA & LYMPHOMA, 2000, 40 (1-2) : 1 - 24
  • [26] Implementation of Diagnostic Flow Cytometry Allows for the Dissection of Age Related Loss of Y Chromosome from Myelodysplastic Syndrome (MDS)
    Oelschlaegel, Uta
    Mohr, Brigitte
    Sockel, Katja
    Ehninger, Gerhard
    Bornhauser, Martin
    Platzbecker, Uwe
    BLOOD, 2016, 128 (22)
  • [27] IMPLEMENTATION OF DIAGNOSTIC FLOW CYTOMETRY ALLOWS FOR THE DISSECTION OF AGE RELATED LOSS OF Y CHROMOSOME FROM MYELODYSPLASTIC SYNDROME (MDS)
    Oelschlaegel, U.
    Mohr, B.
    Sockel, K.
    Ehninger, G.
    Bornhaeuser, M.
    Platzbecker, U.
    LEUKEMIA RESEARCH, 2017, 55 : S98 - S98
  • [28] Where diagnosis for myelodysplastic neoplasms (MDS) stands today and where it will go: The role of flow cytometry in evaluation of MDS
    Wang, Wei
    Khoury, Joseph D.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2023, 104 (01) : 12 - 14
  • [29] Quantitative analysis of flow cytometry immumophenotyping data for aiding in the diagnosis of myelodysplastic syndromes (MDS).
    Nishino, HT
    Zu, YL
    Rice, L
    Baker, KR
    McCarthy, JJ
    Zeng, G
    Popat, UR
    Carrum, G
    Chang, CC
    BLOOD, 2004, 104 (11) : 267B - 267B
  • [30] Treatment strategies and issues in low/intermediate-1-risk myelodysplastic syndrome (MDS) patients
    Bowen, DT
    SEMINARS IN ONCOLOGY, 2005, 32 (04) : S16 - S23
12345